Celltrion
068270.KS
#933
Rank
โ‚น2.520 T
Marketcap
โ‚น10,993
Share price
3.15%
Change (1 day)
8.42%
Change (1 year)
Celltrion is a Korean pharmaceutical company headquartered in Incheon, South Korea. Celltrion Healthcare conducts worldwide marketing, sales, and distribution of biological medicines developed by Celltrion.

EPS for Celltrion (068270.KS)

EPS in 2025 (TTM): โ‚น165.10

According to Celltrion 's latest financial reports the company's current EPS (TTM) is โ‚น179.75. an increase over its 2024 EPS that were of โ‚น116.87.

EPS history for Celltrion from 2007 to 2025

Annual EPS

Year EPS Change
2025โ‚น308.14163.66%
2024โ‚น116.87-53.73%
2023โ‚น252.59-2.08%
2022โ‚น257.96-11.72%
2021โ‚น292.202.03%
2020โ‚น286.3882.8%
2019โ‚น156.6618.31%
2018โ‚น132.41-36.33%
2017โ‚น207.98161.25%
2016โ‚น79.612.86%
2015โ‚น77.4017.84%
2014โ‚น65.685.87%
2013โ‚น62.04-70.85%
2012โ‚น212.82134.09%
2011โ‚น90.9143.59%
2010โ‚น63.3274.49%
2009โ‚น36.29317.8%
2008โ‚น8.68-71.7%
2007โ‚น30.69